Indications: Panobinostat is an HDAC inhibitor indicated for the treatment of patients already receiving bortezomib and immunomodulators. Histone deacetylase (HDAC) inhibitors are a group of drugs that can affect whether genes are active or turned on in cells
Let us work together to protect precious health